Health Policy & Advocacy
Basic InformationMore InformationLatest News
Nursing Home Staff Closest to Patients Are Least Likely to Get COVID VaccinesLowering Medicare Age Could Help Close Racial Gaps in Health Care: StudyHow Trust in Science Can Make You Vulnerable to 'Pseudoscience'Major Medical Groups Call for Mandatory COVID Vaccination for Health WorkersU.S. to Stick With International Travel RestrictionsPatients of Color Less Likely to Get Specialist Care Than White PatientsEven at Same Hospital, Black Patients Face More Complications Than WhitesMany Patients Billed for Preventive Care That Should Be Free: StudyDrug Makers Reach $26 Billion Deal on Opioid LawsuitsCOVID Drove Biggest Drop in U.S. Life Expectancy Since World War IIU.S. Issues Toughest Travel Alert for Britain As COVID Cases There ClimbLong Distance to Care Can Mean Worse Outcomes for Young Cancer PatientsCanada May Open Borders to Fully Vaccinated Americans by Mid-AugustWhy Many Black & Hispanic Americans Distrust COVID Vaccines$345 Million Settlement Proposed in EpiPen LawsuitsAHA News: How Healthy Is Your Neighborhood? Where You Live Can Greatly Affect Heart, Brain HealthExtreme Heat Hits Poorer Neighborhoods HarderFive Neutrogena and Aveeno Spray Sunscreens Recalled Due to BenzeneMany States Move to Ban Vaccine Mandates, Passports in Public SchoolsWHO Calls for Global Registry of Human Genome EditingMost Cancer Screenings Make Big Rebound After Pandemic DeclineBlack Churches Could Be Key to Boosting Vaccination RatesFDA Head Asks for Investigation Into Alzheimer's Drug ApprovalWhy Even the Healthy Need a Primary Care DoctorClimate Change Already Causes 5 Million Extra Deaths Per YearIs Medicare Overspending? Costco Prices Much Less for Generic DrugsLanguage Barriers Keep 25 million in U.S. From Good Health CareState Lotteries Don't Boost COVID Vaccination Numbers: StudyBlood Shortages Causing Surgery Delays Across U.S.Walmart to Offer Low-Priced InsulinCould Home Test for Colon Cancer Mean a Big Medical Bill to Come?Juul to Pay $40 Million in N.C. Case Over Vaping's Harm to TeensHospitals: One Reason COVID Is More Lethal for Black AmericansU.S. Supreme Court Strikes Down Challenge to Affordable Care ActHow Secure Is Your Health or Fitness App?Doctors May Be Overprescribing Opioids After SurgeriesMost Editors at Leading Medical Journals Are White, Study FindsAHA News: Why Everyone Should Care About Health Disparities – And What to Do About ThemUS to Send 500 Million COVID Vaccine Doses to Countries Desperate for ShotsThink You Can Skip That Annual Physical?  Think AgainYour Doctor Appointments Might Look Different Post-PandemicU.S. Blood Supply Is Safe From Coronavirus, Study FindsThink You Can Spot Fake News? Many Can'tTelehealth Is Growing in Use, Acceptance Among Americans: PollAHA News: Deep Disparities Persist in Who Gets Exposed to Secondhand SmokeMany Pre-Surgery Tests Are Useless, So Why Are Hospitals Still Using Them?U.S. Officials Say 50% of American Adults Are Now Fully VaccinatedMore Pot-Linked Poisoning Cases as Edibles' Popularity BoomsU.S. Issues Tough Travel Warnings for Japan Ahead of OlympicsScience Studies Most Likely to Be Wrong Are the Most Widely Read
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance

Most Cancer Screenings Make Big Rebound After Pandemic Decline

HealthDay News
by Robert Preidt
Updated: Jul 12th 2021

new article illustration

MONDAY, July 12, 2021 (HealthDay News) -- A major U.S. hospital system had a strong rebound in most cancer screening tests after a steep drop-off in the early months of the COVID-19 pandemic, a new study shows.

The findings are based on an analysis of data from the Boston-based Mass General Brigham system. Depending on the type of test, between March and June of 2020, the number of cancer screenings dropped off between 65% and 82%, while declines ranged from 4% to 44% from June to September 2020.

In some cases, the drop-off was short-lived. Between September and December of 2020, screenings for breast, prostate, cervical and lung cancer surpassed pre-pandemic levels, the study found. Colonoscopy screening to detect colon cancer did not return to normal levels, however.

"The increase in screening tests that was identified from September to December 2020 helped to recover some of the 'missed' cancer diagnoses from earlier time periods," said study co-author Dr. Chris Labaki of the Dana-Farber Cancer Institute, in Boston. "However, more efforts are still needed to ensure the implementation of large screening campaigns as a significant proportion of cancers remain undiagnosed."

The researchers suspect the reason colonoscopy didn't rebound is that it is the most invasive of the cancer screening tests, requiring anesthesia. They said some patients may have opted instead for home-based stool tests.

Despite the resurgence of most types of screening, the declines early in the pandemic also led to fewer cancer diagnoses, which could have long-term consequences.

Between March and June of last year, 1,985 positive tests were reported, compared with 3,476 between September and December 2020. That means 1,187 cancer diagnoses were "missed" from March to June 2020 because of reduced screening, the researchers said in a Dana-Farber news release.

Of those, 323 were "recovered" between September and December 2020, but the study did not say whether the cancers were found at later stages. For colonoscopy, no diagnoses were recovered and 38 positive diagnoses were missed during the study period.

The investigators also found that racial disparities widened.

While there was an overall increase in mammograms between September and December 2020, fewer Black women and Hispanic women had them during that period than in the three months before the pandemic.

"These findings are concerning and suggest the pandemic may accentuate racial disparities related to cancer screening," the authors concluded.

The findings were recently published as a letter in the journal Cancer Cell.

Study co-author Dr. Quoc-Dien Trinh predicted that the widening screening gap due to COVID-19 will worsen racial disparities in cancer death rates. Trinh is co-director of the Dana-Farber/Brigham and Women's Prostate Cancer Center.

In some cases, the delayed diagnoses are expected to result in poor patient outcomes, added study co-author Dr. Toni Choueiri, director of the Lank Center for Genitourinary Oncology at Dana-Farber.

More information

The U.S. National Cancer Institute has more on cancer screening.

SOURCE: Dana-Farber Cancer Institute, news release, July 7, 2021


Amazon Smile


Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.


powered by centersite dot net